Inability of several mutagen-blocking agents to inhibit 1,2-dimethylhydrazine-induced DNA-damaging activity in colonic epithelium.
D019813:1,2-Dimethylhydrazine; D000111:Acetylcysteine / Q000494:pharmacology; D000818:Animals; D002273:Carcinogens / Q000037:antagonists & inhibitors*; D002467:Cell Nucleus / Q000187:drug effects; D003106:Colon / Q000187:drug effects* / Q000648:ultrastructure; D003373:Coumaric Acids / Q000494:pharmacology; D003474:Curcumin / Q000494:pharmacology; D004127:Dimethylhydrazines / Q000037:antagonists & inhibitors*; D004610:Ellagic Acid / Q000494:pharmacology; D004848:Epithelium / Q000187:drug effects; D005260:Female; D005978:Glutathione / Q000494:pharmacology; D008763:Methylhydrazines / Q000037:antagonists & inhibitors*; D051379:Mice; D008810:Mice, Inbred C57BL; D009154:Mutation; D011794:Quercetin / Q000494:pharmacology
D002273:Carcinogens; D003373:Coumaric Acids; D004127:Dimethylhydrazines; D008763:Methylhydrazines; D004610:Ellagic Acid; D011794:Quercetin; C004999:ferulic acid; D005978:Glutathione; D003474:Curcumin; D019813:1,2-Dimethylhydrazine; D000111:Acetylcysteine